• Neurontin
• Abuse
• Addiction
• Anger
• Anxiety
• Attorney
• Class Action
• Dangers
• Depression
• Drug
• Effects
• Information
• Lawsuit
• Litigation
• Overdose
• Pain
• Replacement
• Side Effects
• Suicide
• Uses
• Warnings
• Withdrawal
• Contact a Lawyer

Find a Lawyer in Your State

Need Help?

• Accutane®
• Cerebral Palsy
• Darvocet®
• Denture Cream
• Depuy ASR™ Hip Implant
• Fosamax® Femur Fracture
• MiniMed Insulin Pump
• Multaq®
• Nephrogenic Systemic Fibrosis
• Paxil® Birth Defects
• Propecia®
• Shoulder Pain Pump
• Topamax®
• Truck Accident Lawyer
• Wellbutrin®
• Yaz® Birth Control

Neurontin addiction has been the subject of recent debate in terms of off label drug marketing. Neurontin is a prescription drug that has been studied in the United States since 1983. The FDA approved Neurontin in 1994 to treat seizures in epileptic patients (in conjunction with complimentary therapies) and to treat nerve pain associated with shingles and herpes. Originally, Neurontin was manufactured by Parke-Davis, but was sold to Pfizer in 2000.

Neurontin is one of the best selling drugs in the world, with annual revenues totaling at almost three billion dollars. This drug has not achieved these sales numbers because of prescriptions administered for its approved uses. It is estimated that between seventy to ninety percent of all Neurontin prescriptions are sold for off-label use.

It is illegal for the manufacturer of prescription drugs to promote their product for uses that have not been approved by the Federal Drug Administration. Doctors who prescribe medications for off-label use are not subject to the same federal laws.

In May 2004, Pfizer, a multinational pharmaceutical giant, plead guilty to allegations of illegally marketing Neurontin for eleven types of off-label use. Pfizer was required to pay $430 million dollars in civil and criminal penalties for the illegal action of marketing their product for off-label use.

Pfizer had been marketing their product for the treatment of a myriad of ailments not approved by the FDA. Neurontin has been widely prescribed for the following ailments that have not been evaluated or proven effective by the FDA: bipolar disorder, pain syndromes, Reflex Sympathetic Dystrophy (RSD), Attention Deficit Disorder, migraines, and a number of other health problems.

In terms of off-label use of Neurontin, addiction treatments have also incorporated using Neurontin to treat seizures associated with drug and alcohol withdrawal. Neurontin addiction therapy is also utilized to treat cocaine addictions. Though often prescribed in Neurontin addiction therapy, there is no evidence to suggest that taking Neurontin helps treat the seizures associated with drug and alcohol withdrawal.

Taking Neurontin for its approved uses in the manner that has been prescribed by a medical professional has given no indication of causing a Neurontin addiction. If you are taking Neurontin, it is important to discuss treatment options with your doctor prior to making any changes in your treatment regiment. At least one week of decreased dosing should be administered prior to the discontinuation of Neurontin treatment. The discontinuation of this prescription medication has been proven to yield an increased risk of subsequent seizures in some patients.

If you are concerned about Neurontin addiction or have questions about Neurontin addiction therapy uses, you may wish to speak to a medical professional who can address these issues in greater detail.

"FDA requests Neurontin study data"

The FDA has requested 14 drugmakers to check their study data to see if use of epilepsy drugs results in suicidal behavior or thoughts, giving the drugmakers six months to respond.

Sales of anti-seizure drugs in the U.S. during 2004 were th...

» Read More

"Pfizer Sued Again Over Improper Marketing of Neurontin"

Just weeks after Pfizer and its Warner-Lambert Co. unit were penalized $430 million in federal and state courts for selling Neurontin for purposes that have not yet been FDA approved, the company is again under fire for fraudulent marketing practices. ...

» Read More

"Pfizer to Settle Neurontin Marketing Suit"

The world''s largest drug manufacturer, Pfizer, Inc., agreed to pay at least $400 million in order to settle civil charges regarding kickbacks to encourage doctors to prescribe the anti-epileptic drug Neurontin for other purposes.

The se...

» Read More

• Accutane® |
• Acetaminophen |
• Actavis Information |
• Actos® |
• Amiodarone |
• Trasylol® - Aprotinin Injection |
• Avandia® |
• Baycol® |
• Bextra® |
• Botox |
• Byetta® |
• Celebrex |
• Cellcept |
• Chantix® |
• Cipro Side Effects |
• Crestor |
• Darvocet |
• Darvon® |
• Defective Drug FAQ |
• Common Defective Drugs |
• Depakote® |
• Drug Company Information |
• Defective Drug Side Effects |
• Duragesic Patch |
• Exjade |
• Fentanyl |
• Fen Phen |
• Fleet Phospho Soda |
• Fluoroquinolone Antibiotics |
• Fosamax |
• Gadolinium |
• Gardasil |
• Gleevec |
• Heparin |
• Humira and Remicade |
• Hydroquinone |
• Hydroxycut |
• Januvia® and Janumet® Information |
• Kava Kava |
• Ketek |
• Lariam |
• Levaquin |
• Lupron (Leuprolide) |
• Meridia |
• Multaq® |
• Naproxen (Aleve) |
• Natrecor |
• Neurontin |
• Nexium® (Esomeprazole Magnesium) Heartburn Relief |
• NuvaRing® |
• Ocella Information |
• Osteonecrosis and Fosamax |
• Oxycontin |
• Palladone |
• Paxil |
• Permax |
• Plavix |
• PPA |
• Pradaxa® |
• Prevacid® |
• Prilosec® |
• Procrit |
• Propecia® (Finasteride) |
• Propoxyphene |
• Protonix® |
• Protopic |
• Prozac |
• What is Quinine? |
• Rapamune® Lawyer |
• Raptiva |
• Reglan |
• Remicade Lawsuit |
• Rezulin |
• Risperdal |
• Ritalin |
• Serevent |
• Seroquel |
• Serzone |
• Tequin |
• Thimerosal |
• Topamax® (Topiramate) |
• Viagra® |
• Wellbutrin® |
• Xenical |
• Yasmin® |
• Yaz Birth Control Lawyer |
• Zelnorm |
• Zocor® Medication Information |
• Zoloft |
• Zyprexa |